{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:12:52Z","timestamp":1783930372036,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00228-026-04110-x","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:16:34Z","timestamp":1781576194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between anamorelin therapy and renal function in patients with cancer cachexia: a propensity score\u2013matched retrospective study"],"prefix":"10.1007","volume":"82","author":[{"given":"Ayaka","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2026-2142","authenticated-orcid":false,"given":"Takahiro","family":"Sumimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8452-7971","authenticated-orcid":false,"given":"Ryota","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4949-362X","authenticated-orcid":false,"given":"Ryosuke","family":"Tatsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4928-0395","authenticated-orcid":false,"given":"Naoki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0322-9356","authenticated-orcid":false,"given":"Hiroki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"3","key":"4110_CR1","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/jcsm.13216","volume":"14","author":"T Shukuya","year":"2023","unstructured":"Shukuya T, Takahashi K, Shintani Y, Miura K, Sekine I, Takayama K, Inoue A, Okamoto I, Kiura K, Kawaguchi T, Yamamoto N, Miyaoka E, Yoshino I, Date H (2023) Epidemiology, risk factors and impact of cachexia on patient outcome: results from the Japanese Lung Cancer Registry Study. J Cachexia Sarcopenia Muscle 14(3):1274\u20131285. https:\/\/doi.org\/10.1002\/jcsm.13216","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"4110_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.21873\/anticanres.16188","volume":"43","author":"H Watanabe","year":"2023","unstructured":"Watanabe H, Oshima T (2023) The latest treatments for cancer cachexia: an overview. Anticancer Res 43(2):511\u2013521. https:\/\/doi.org\/10.21873\/anticanres.16188","journal-title":"Anticancer Res"},{"issue":"7","key":"4110_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/1049909119886833","volume":"37","author":"LAF Cordeiro","year":"2020","unstructured":"Cordeiro LAF, Silva TH, de Oliveira LC, Neto JFN (2020) Systemic inflammation and nutritional status in patients on palliative cancer care: a systematic review of observational studies. Am J Hosp Palliat Care 37(7):565\u2013571. https:\/\/doi.org\/10.1177\/1049909119886833","journal-title":"Am J Hosp Palliat Care"},{"issue":"3","key":"4110_CR4","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/jcsm.12705","volume":"12","author":"TJ Wilkinson","year":"2021","unstructured":"Wilkinson TJ, Miksza J, Yates T, Lightfoot CJ, Baker LA, Watson EL, Zaccardi F, Smith AC (2021) Association of sarcopenia with mortality and end-stage renal disease in those with chronic kidney disease: a UK Biobank study. J Cachexia Sarcopenia Muscle 12(3):586\u2013598. https:\/\/doi.org\/10.1002\/jcsm.12705","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4110_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2180373","volume":"2018","author":"S Mihai","year":"2018","unstructured":"Mihai S, Codrici E, Popescu ID, Enciu AM, Albulescu L, Necula LG, Mambet C, Anton G, Tanase C (2018) Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome. J Immunol Res 2018:2180373. https:\/\/doi.org\/10.1155\/2018\/2180373","journal-title":"J Immunol Res"},{"key":"4110_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000517669","volume":"199","author":"AY Wang","year":"2021","unstructured":"Wang AY, Kovesdy CP (2021) Nutrition and obesity impacts on kidney health. Contrib Nephrol 199:24\u201342. https:\/\/doi.org\/10.1159\/000517669","journal-title":"Contrib Nephrol"},{"issue":"2","key":"4110_CR7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4235\/agmr.23.0215","volume":"28","author":"S Yoon","year":"2024","unstructured":"Yoon S, Ko NG, Lee YJ (2024) Geriatric nutritional risk index as a possible predictor of decline in kidney function in older people. Ann Geriatr Med Res 28(2):164\u2013170. https:\/\/doi.org\/10.4235\/agmr.23.0215","journal-title":"Ann Geriatr Med Res"},{"key":"4110_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/nu9030208","author":"Y Zha","year":"2017","unstructured":"Zha Y, Qian Q (2017) Protein nutrition and malnutrition in CKD and ESRD. Nutrients. https:\/\/doi.org\/10.3390\/nu9030208","journal-title":"Nutrients"},{"key":"4110_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/nu14173634","author":"J Zhang","year":"2022","unstructured":"Zhang J, Xiao X, Wu Y, Yang J, Zou Y, Zhao Y, Yang Q, Liu F (2022) Prognostic nutritional index as a predictor of diabetic nephropathy progression. Nutrients. https:\/\/doi.org\/10.3390\/nu14173634","journal-title":"Nutrients"},{"issue":"6762","key":"4110_CR10","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/45230","volume":"402","author":"M Kojima","year":"1999","unstructured":"Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402(6762):656\u2013660. https:\/\/doi.org\/10.1038\/45230","journal-title":"Nature"},{"issue":"11","key":"4110_CR11","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1210\/endo.141.11.7757","volume":"141","author":"Y Date","year":"2000","unstructured":"Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M (2000) Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141(11):4255\u20134261. https:\/\/doi.org\/10.1210\/endo.141.11.7757","journal-title":"Endocrinology"},{"issue":"6817","key":"4110_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/35051587","volume":"409","author":"M Nakazato","year":"2001","unstructured":"Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S (2001) A role for ghrelin in the central regulation of feeding. Nature 409(6817):194\u2013198. https:\/\/doi.org\/10.1038\/35051587","journal-title":"Nature"},{"issue":"6806","key":"4110_CR13","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/35038090","volume":"407","author":"M Tsch\u00f6p","year":"2000","unstructured":"Tsch\u00f6p M, Smiley DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature 407(6806):908\u2013913. https:\/\/doi.org\/10.1038\/35038090","journal-title":"Nature"},{"issue":"4","key":"4110_CR14","doi-asserted-by":"publisher","first-page":"e94373","DOI":"10.1371\/journal.pone.0094373","volume":"9","author":"K Fujimura","year":"2014","unstructured":"Fujimura K, Wakino S, Minakuchi H, Hasegawa K, Hosoya K, Komatsu M, Kaneko Y, Shinozuka K, Washida N, Kanda T, Tokuyama H, Hayashi K, Itoh H (2014) Ghrelin protects against renal damages induced by angiotensin-II via an antioxidative stress mechanism in mice. PLoS ONE 9(4):e94373. https:\/\/doi.org\/10.1371\/journal.pone.0094373","journal-title":"PLoS ONE"},{"issue":"12","key":"4110_CR15","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/bjc.2016.160","volume":"114","author":"Y Yanagimoto","year":"2016","unstructured":"Yanagimoto Y, Takiguchi S, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Yamasaki M, Miyata H, Nakajima K, Hosoda H, Kangawa K, Mori M, Doki Y (2016) Improvement of cisplatin-related renal dysfunction by synthetic ghrelin: a prospective randomised phase II trial. Br J Cancer 114(12):1318\u20131325. https:\/\/doi.org\/10.1038\/bjc.2016.160","journal-title":"Br J Cancer"},{"issue":"1","key":"4110_CR16","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.1038\/s41598-019-42657-1","volume":"9","author":"K Azushima","year":"2019","unstructured":"Azushima K, Uneda K, Wakui H, Ohki K, Haruhara K, Kobayashi R, Haku S, Kinguchi S, Yamaji T, Minegishi S, Ishigami T, Yamashita A, Tamura K (2019) Effects of rikkunshito on renal fibrosis and inflammation in angiotensin II-infused mice. Sci Rep 9(1):6201. https:\/\/doi.org\/10.1038\/s41598-019-42657-1","journal-title":"Sci Rep"},{"issue":"5","key":"4110_CR17","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2217\/fon.14.14","volume":"10","author":"DC Currow","year":"2014","unstructured":"Currow DC, Abernethy AP (2014) Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome. Future Oncol 10(5):789\u2013802. https:\/\/doi.org\/10.2217\/fon.14.14","journal-title":"Future Oncol"},{"issue":"8","key":"4110_CR18","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1517\/14656566.2015.1041500","volume":"16","author":"H Zhang","year":"2015","unstructured":"Zhang H, Garcia JM (2015) Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC. Expert Opin Pharmacother 16(8):1245\u20131253. https:\/\/doi.org\/10.1517\/14656566.2015.1041500","journal-title":"Expert Opin Pharmacother"},{"key":"4110_CR19","unstructured":"Ono Pharmaceutical Co. L (2023) The drug interview form of Anamorelin Hydrochloride (ADLUMIZ\u00ae). In: ed"},{"issue":"1","key":"4110_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00520-012-1500-1","volume":"21","author":"JM Garcia","year":"2013","unstructured":"Garcia JM, Friend J, Allen S (2013) Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study. Support Care Cancer 21(1):129\u2013137. https:\/\/doi.org\/10.1007\/s00520-012-1500-1","journal-title":"Support Care Cancer"},{"issue":"5","key":"4110_CR21","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1634\/theoncologist.12-5-594","volume":"12","author":"JM Garcia","year":"2007","unstructured":"Garcia JM, Polvino WJ (2007) Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers. Oncologist 12(5):594\u2013600. https:\/\/doi.org\/10.1634\/theoncologist.12-5-594","journal-title":"Oncologist"},{"issue":"3","key":"4110_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ghir.2008.12.003","volume":"19","author":"JM Garcia","year":"2009","unstructured":"Garcia JM, Polvino WJ (2009) Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers. Growth Horm IGF Res 19(3):267\u2013273. https:\/\/doi.org\/10.1016\/j.ghir.2008.12.003","journal-title":"Growth Horm IGF Res"},{"issue":"3","key":"4110_CR23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/cncr.31128","volume":"124","author":"N Katakami","year":"2018","unstructured":"Katakami N, Uchino J, Yokoyama T, Naito T, Kondo M, Yamada K, Kitajima H, Yoshimori K, Sato K, Saito H, Aoe K, Tsuji T, Takiguchi Y, Takayama K, Komura N, Takiguchi T, Eguchi K (2018) Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04). Cancer 124(3):606\u2013616. https:\/\/doi.org\/10.1002\/cncr.31128","journal-title":"Cancer"},{"issue":"8","key":"4110_CR24","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1007\/s00520-016-3144-z","volume":"24","author":"K Takayama","year":"2016","unstructured":"Takayama K, Katakami N, Yokoyama T, Atagi S, Yoshimori K, Kagamu H, Saito H, Takiguchi Y, Aoe K, Koyama A, Komura N, Eguchi K (2016) Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial. Support Care Cancer 24(8):3495\u20133505. https:\/\/doi.org\/10.1007\/s00520-016-3144-z","journal-title":"Support Care Cancer"},{"issue":"4","key":"4110_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/s1470-2045(15)00558-6","volume":"17","author":"JS Temel","year":"2016","unstructured":"Temel JS, Abernethy AP, Currow DC, Friend J, Duus EM, Yan Y, Fearon KC (2016) Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol 17(4):519\u2013531. https:\/\/doi.org\/10.1016\/s1470-2045(15)00558-6","journal-title":"Lancet Oncol"},{"issue":"5","key":"4110_CR26","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/s1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489\u2013495. https:\/\/doi.org\/10.1016\/s1470-2045(10)70218-7","journal-title":"Lancet Oncol"},{"issue":"1","key":"4110_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.ajkd.2010.02.344","volume":"56","author":"M Horio","year":"2010","unstructured":"Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S (2010) Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis 56(1):32\u201338. https:\/\/doi.org\/10.1053\/j.ajkd.2010.02.344","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"4110_CR28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000343822","volume":"84","author":"Y Inoue","year":"2013","unstructured":"Inoue Y, Iwata T, Okugawa Y, Kawamoto A, Hiro J, Toiyama Y, Tanaka K, Uchida K, Mohri Y, Miki C, Kusunoki M (2013) Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer. Oncology 84(2):100\u2013107. https:\/\/doi.org\/10.1159\/000343822","journal-title":"Oncology"},{"issue":"1","key":"4110_CR29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/s12876-020-01566-8","volume":"20","author":"M Oshima","year":"2020","unstructured":"Oshima M, Okano K, Suto H, Ando Y, Kamada H, Masaki T, Takahashi S, Shibata T, Suzuki Y (2020) Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer. BMC Gastroenterol 20(1):423. https:\/\/doi.org\/10.1186\/s12876-020-01566-8","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"4110_CR30","first-page":"1001","volume":"85","author":"T Onodera","year":"1984","unstructured":"Onodera T, Goseki N, Kosaki G (1984) [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai Zasshi 85(9):1001\u20131005","journal-title":"Nihon Geka Gakkai Zasshi"},{"issue":"10","key":"4110_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165403","volume":"11","author":"TC Wong","year":"2016","unstructured":"Wong TC, Su HY, Chen YT, Wu PY, Chen HH, Chen TH, Hsu YH, Yang SH (2016) Ratio of C-reactive protein to albumin predicts muscle mass in adult patients undergoing hemodialysis. PLoS One 11(10):e0165403. https:\/\/doi.org\/10.1371\/journal.pone.0165403","journal-title":"PLoS One"},{"key":"4110_CR32","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.2147\/ott.S137002","volume":"10","author":"HJ Xu","year":"2017","unstructured":"Xu HJ, Ma Y, Deng F, Ju WB, Sun XY, Wang H (2017) The prognostic value of C-reactive protein\/albumin ratio in human malignancies: an updated meta-analysis. Onco Targets Ther 10:3059\u20133070. https:\/\/doi.org\/10.2147\/ott.S137002","journal-title":"Onco Targets Ther"},{"issue":"3","key":"4110_CR33","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant 48(3):452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"4110_CR34","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.kint.2016.12.013","volume":"91","author":"C Garofalo","year":"2017","unstructured":"Garofalo C, Borrelli S, Minutolo R, Chiodini P, De Nicola L, Conte G (2017) A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney Int 91(5):1224\u20131235. https:\/\/doi.org\/10.1016\/j.kint.2016.12.013","journal-title":"Kidney Int"},{"issue":"6","key":"4110_CR35","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/ije\/dyad111","volume":"52","author":"AC van der Burgh","year":"2023","unstructured":"van der Burgh AC, Sedaghat S, Ikram MA, Hoorn EJ, Chaker L (2023) Trajectories of kidney function and risk of mortality. Int J Epidemiol 52(6):1959\u20131967. https:\/\/doi.org\/10.1093\/ije\/dyad111","journal-title":"Int J Epidemiol"},{"issue":"4","key":"4110_CR36","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1177\/10600280241273191","volume":"59","author":"EF Barreto","year":"2025","unstructured":"Barreto EF, Gaggani AM, Hernandez BN, Amatullah N, Culley CM, Stottlemyer B, Murugan R, Ozrazgat-Baslanti T, Bihorac A, Kellum JA, Kashani KB, Rule AD, Kane-Gill SL (2025) The Acute Kidney Intervention and Pharmacotherapy (AKIP) list: standardized list of medications that are renally eliminated and nephrotoxic in the acutely ill. Ann Pharmacother 59(4):371\u2013377. https:\/\/doi.org\/10.1177\/10600280241273191","journal-title":"Ann Pharmacother"},{"issue":"2","key":"4110_CR37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin PC (2011) Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 10(2):150\u2013161. https:\/\/doi.org\/10.1002\/pst.433","journal-title":"Pharm Stat"},{"issue":"7","key":"4110_CR38","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.2215\/cjn.00020110","volume":"5","author":"JP van Kuijk","year":"2010","unstructured":"van Kuijk JP, Flu WJ, Chonchol M, Hoeks SE, Winkel TA, Verhagen HJ, Bax JJ, Poldermans D (2010) Temporary perioperative decline of renal function is an independent predictor for chronic kidney disease. Clin J Am Soc Nephrol 5(7):1198\u20131204. https:\/\/doi.org\/10.2215\/cjn.00020110","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"4110_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MCO.0b013e32832a7902","volume":"12","author":"DC McMillan","year":"2009","unstructured":"McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12(3):223\u2013226. https:\/\/doi.org\/10.1097\/MCO.0b013e32832a7902","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"3","key":"4110_CR40","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3305\/nh\/2012.27.3.5567","volume":"27","author":"KV Gomes de Lima","year":"2012","unstructured":"Gomes de Lima KV, Maio R (2012) Nutritional status, systemic inflammation and prognosis of patients with gastrointestinal cancer. Nutr Hosp 27(3):707\u2013714. https:\/\/doi.org\/10.3305\/nh\/2012.27.3.5567","journal-title":"Nutr Hosp"},{"issue":"4","key":"4110_CR41","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ejim.2011.05.005","volume":"22","author":"CF Christiansen","year":"2011","unstructured":"Christiansen CF, Johansen MB, Langeberg WJ, Fryzek JP, S\u00f8rensen HT (2011) Incidence of acute kidney injury in cancer patients: a Danish population-based cohort study. Eur J Intern Med 22(4):399\u2013406. https:\/\/doi.org\/10.1016\/j.ejim.2011.05.005","journal-title":"Eur J Intern Med"},{"issue":"9","key":"4110_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2025.101069","volume":"7","author":"Y Miyamoto","year":"2025","unstructured":"Miyamoto Y, Andes LJ, Koyama AK, Xu F, Pavkov ME (2025) Association between cancer and incident acute kidney injury among Medicare fee-for-service population. Kidney Med 7(9):101069. https:\/\/doi.org\/10.1016\/j.xkme.2025.101069","journal-title":"Kidney Med"},{"issue":"6","key":"4110_CR43","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1210\/jcem.87.6.8739","volume":"87","author":"S Gnanapavan","year":"2002","unstructured":"Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M (2002) The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87(6):2988\u20132991. https:\/\/doi.org\/10.1210\/jcem.87.6.8739","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"4110_CR44","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2174\/187152706777452227","volume":"5","author":"R Nogueiras","year":"2006","unstructured":"Nogueiras R, Perez-Tilve D, Wortley KE, Tsch\u00f6p M (2006) Growth hormone secretagogue (ghrelin-) receptors\u2013a complex drug target for the regulation of body weight. CNS Neurol Disord Drug Targets 5(3):335\u2013343. https:\/\/doi.org\/10.2174\/187152706777452227","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"11","key":"4110_CR45","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1055\/s-0029-1233462","volume":"41","author":"B Ueberberg","year":"2009","unstructured":"Ueberberg B, Unger N, Saeger W, Mann K, Petersenn S (2009) Expression of ghrelin and its receptor in human tissues. Horm Metab Res 41(11):814\u2013821. https:\/\/doi.org\/10.1055\/s-0029-1233462","journal-title":"Horm Metab Res"},{"key":"4110_CR46","doi-asserted-by":"publisher","DOI":"10.1523\/eneuro.0053-14.2015","author":"M Wellman","year":"2015","unstructured":"Wellman M, Abizaid A (2015) Growth hormone secretagogue receptor dimers: a new pharmacological target. eNeuro. https:\/\/doi.org\/10.1523\/eneuro.0053-14.2015","journal-title":"eNeuro"},{"issue":"6","key":"4110_CR47","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.juro.2014.11.098","volume":"193","author":"GX Sun","year":"2015","unstructured":"Sun GX, Ding R, Li M, Guo Y, Fan LP, Yue LS, Li LY, Zhao M (2015) Ghrelin attenuates renal fibrosis and inflammation of obstructive nephropathy. J Urol 193(6):2107\u20132115. https:\/\/doi.org\/10.1016\/j.juro.2014.11.098","journal-title":"J Urol"},{"key":"4110_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00271","volume":"5","author":"N Fujitsuka","year":"2014","unstructured":"Fujitsuka N, Uezono Y (2014) Rikkunshito, a ghrelin potentiator, ameliorates anorexia\u2013cachexia syndrome. Front Pharmacol 5:271. https:\/\/doi.org\/10.3389\/fphar.2014.00271","journal-title":"Front Pharmacol"},{"issue":"1","key":"4110_CR49","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12882-019-1306-1","volume":"20","author":"M Seki","year":"2019","unstructured":"Seki M, Nakayama M, Sakoh T, Yoshitomi R, Fukui A, Katafuchi E, Tsuda S, Nakano T, Tsuruya K, Kitazono T (2019) Blood urea nitrogen is independently associated with renal outcomes in Japanese patients with stage 3\u20135 chronic kidney disease: a prospective observational study. BMC Nephrol 20(1):115. https:\/\/doi.org\/10.1186\/s12882-019-1306-1","journal-title":"BMC Nephrol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04110-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04110-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04110-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:57:32Z","timestamp":1783929452000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04110-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4110"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04110-x","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Oita University Faculty of Medicine Ethics Committee (approval number 2730) before study initiation. All procedures were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics appoval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}